# US 2004/0083504 A1 · Sequence regulating the anther-specific expression of a gene and its use in the production of androsterile plants and hybrid seeds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0083504 A1
- Document ID: US20040083504A1
- Status: Published application
- Kind: A1
- Application number: 10/240,299
- Filed: 2003-01-28
- Published: 2004-04-29
- Earliest claimed: 2000-03-31
- Assignees: Consejo Superior de Investigaciones Cientificas
- Inventors: Maria Dolores Gomez Jimenez; Luis Antonio Cañas Clemente; Francisco Madueño Albi; Jose Pio Beltran Porter
- Web page: https://patentgrep.com/patent/US20040083504A1

## CPC

- C12N 15/8289: {Male sterility}
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07K 14/415: from plants
- C12N 15/8222: {Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation}
- C12N 15/8231: {Male-specific, e.g. anther, tapetum, pollen}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The regulatory sequence is useful for the specific expression in anther of a nucleotide sequence of interest, for example, a sequence whose controlled expression under the regulatory sequence causes complete ablation of the anther in the early development stages and allows a user to obtain androsterile plants that are useful for producing hybrid seeds.

## Claims

### Claim 1

A nucleotide sequence regulating the specific expression in anthers of a gene selected from:
a) a nucleotide sequence comprising the nucleotide sequence shown in SEQ ID NO 1;
b) a fragment of any of said SEQ ID NO 1 that maintains the capacity to regulate the specific expression in the anther; and
c) a nucleotide sequence that is substantially analogous to the nucleotide sequence defined in a) or in b).

### Claim 2 (depends on 1)

A regulatory sequence of nucleotides in accordance with claim 1, comprising the nucleotide sequence shown in SEQ ID NO 4.

### Claim 3 (depends on 1, 2)

A DNA construct comprising a nucleotide sequence in accordance with any of claims 1 or 2 and a coding nucleotide sequence of a peptide, polypeptide, protein, activity or RNA.

### Claim 4 (depends on 1, 2, 3)

A recombinant vector comprising a nucleotide sequence in accordance with any of claims 1 or 2, or a DNA construct in accordance with claim 3.

### Claim 5 (depends on 1, 2, 3, 4)

A transformed cell that comprises a nucleotide sequence in accordance with any of claims 1 or 2, or a DNA construct according to claim 3, or a recombinant vector in accordance with claim 4.

### Claim 6 (depends on 1, 2, 3, 4)

A transgenic cell comprising, inserted in its genome, a nucleotide sequence in accordance with any of claims 1 or 2, or a DNA construct according to claim 3, or a recombinant vector in accordance with claim 4.

### Claim 7 (depends on 6)

A transgenic plant comprising at least a transgenic cell in accordance with claim 6.

### Claim 8 (depends on 1, 2, 3)

A transgenic plant in accordance with claim. 7, at least comprising a transgenic cell that contains a DNA construct according to claim 3, wherein said coding nucleotide sequence codes a peptide, polypeptide, protein or activity or RNA that is cytotoxic and whose expression induces the ablation of the anther, and said coding sequence is controlled by a nucleotide sequence according to any of claims 1 or 2.

### Claim 9 (depends on 7)

A transgenic plant according to claim 7, selected from among monocotyledoneous and dicotyledoneous.

### Claim 10 (depends on 7, 8, 9)

The use of a transgenic plant in accordance with any of claims 7 to 9 to produce hybrid seeds.

### Claim 11 (depends on 1, 2, 3)

A method for producing androsterile plants, which comprises transforming a plant with a DNA construct according to claim 3, said DNA construct comprising a coding sequence of promoter activity of the sterility in plants, controlled by a nucleotide sequence according to any of claims 1 or 2, so that said expression of said coding sequence produce the ablation of the anthers.

### Claim 12 (depends on 1, 2, 3)

A method for restoring the fertility of an androsterile plant that comprises transforming said androsterile plant with a DNA construct according to claim 3, said construct comprising a coding sequence of an activity that reverses or restores the fertility that inhibits the activity of ablation of the anthers, controlled by a nucleotide sequence according to any of claims 1 or 2.
